Sarah Matthew crowned Healthcare Communiquétor 2017

So much of her senior consulting is confidential that few people know of her amazing achievements with leading industry bodies such as the ABPI and the DH, and with industry leaders

Pharma could make more of its real world evidence

The report, published in February 2016, says it is 'unacceptable' that, six years after the CDF was set up, the DH and NHS England still do not have data to evaluate ... When the CDF was introduced in 2010, the DH 'encouraged' trusts to collect data to

UK pharma rebate payment doubles in one year

The ABPI, which negotiated the deal with DH in 2013, is keen to see this as 'underwriting' the NHS medicines bill.

Is a UK market access shake-up on the cards?

But the secrecy around these deals irks health economists and doctor groups, as without knowing how much has been knocked off the price that no one outside NICE, the DH and ... I do, however, think there are issues about these commercially confidential

Pharma must engage on the affordability question, says ABPI

The rebates should be helping this, but the ABPI and many other senior executives in the industry told PMLiVE that this money is going back to the DH and NHS England,

Public affairs

Healthcare systems

Pharma perspectives: communications creativity (part 2)

Is pharma marketing less creative than its consumer sector? DH: That old chestnut eh! ... DH: The simple answer is yes! How we do it is another matter.

NICE and ‘ultra orphans’

Provisional evaluation topics chosen by the Department of Health (DH)  . Consultees and commentators identified. Scope prepared by NICE and DH. Evaluation topics officially referred to NICE by DH.

Drug pricing in Ireland

The agreement between the Department of Health (DH), the Health Service Executive (HSE) and the Irish Pharmaceutical Healthcare Association (IPHA) will lead to significant reductions in the prices of both ... The three-year pricing agreement. The latest

New health ministers and re-appointments after reshuffle

Two noticeable absences are Lord Freddy Howe, who has moved out of the DH and over to the Ministry of Defence and David Willetts, formerly the universities and science minister, who

UK names guardian for national health data

Dame Fiona Caldicott is “people’s champion” for medical information. The UK's Department of Health (DH) has appointed Dame Fiona Caldicott as the nation's guardian for health and care ... data. According to the DH, Dame Fiona will be the “patients

NHS names ‘procurement champion’

This broad experience is likely to have been one of the reasons the DH was keen to appoint Lord Carter to his new position.

New chair of the British Pharmacopoeia Commission

UCL's Kevin Taylor to lead body to oversee pharmaceutical standards. The UK's Department of Health (DH) has named Prof Kevin Taylor as the new chair of the British Pharmacopoeia

DH names new chief executive of the MHRA

Ian Hudson to lead UK medicines regulator